ANTI-CD20 CHIMERIC ANTIBODY, IDEC-C2B8 - SAFETY AND CLINICAL ACTIVITYIN THE TREATMENT OF RELAPSED LOW-GRADE OR FOLLICULAR (IWF-A-D) LYMPHOMAS (LG-F NHL)/

Citation
Aj. Grillolopez et al., ANTI-CD20 CHIMERIC ANTIBODY, IDEC-C2B8 - SAFETY AND CLINICAL ACTIVITYIN THE TREATMENT OF RELAPSED LOW-GRADE OR FOLLICULAR (IWF-A-D) LYMPHOMAS (LG-F NHL)/, Experimental hematology, 24(9), 1996, pp. 691-691
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
ISSN journal
0301472X
Volume
24
Issue
9
Year of publication
1996
Pages
691 - 691
Database
ISI
SICI code
0301-472X(1996)24:9<691:ACAI-S>2.0.ZU;2-R